Published in J Assist Reprod Genet on July 01, 1997
STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III. J Exp Med (1944) 24.08
Genetic exchange in Salmonella. J Bacteriol (1952) 23.68
Genetical implications of the structure of deoxyribonucleic acid. Nature (1953) 16.01
The integrated state of viral DNA in SV40-transformed cells. Proc Natl Acad Sci U S A (1968) 8.38
Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J (1991) 6.13
Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med (1989) 5.81
In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science (1992) 5.47
Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc Natl Acad Sci U S A (1979) 5.32
Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat Genet (1994) 4.33
A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med (1995) 4.30
Mechanism of cell transformation by RNA tumor viruses. Annu Rev Microbiol (1971) 4.24
Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirus. Cell (1981) 3.80
Transfer of genes to humans: early lessons and obstacles to success. Science (1995) 3.64
Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1993) 3.49
Mechanisms and applications of DNA-mediated gene transfer in mammalian cells - a review. Gene (1981) 3.46
Size and location of the transforming region in human adenovirus type 5 DNA. Nature (1974) 3.02
Human gene therapy. Science (1992) 2.90
The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res (1993) 2.54
Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci U S A (1992) 2.41
Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector. Science (1992) 1.54
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet (1993) 1.53
Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet (1993) 1.51
Progress towards gene therapy for HIV infection. Gene Ther (1994) 1.50
Human gene therapy: ethics and public policy. Hum Gene Ther (1991) 1.25
Human gene therapy: why draw a line? J Med Philos (1989) 1.10
Resistance to taxol chemotherapy produced in mouse marrow cells by safety-modified retroviruses containing a human MDR-1 transcription unit. Gene Ther (1995) 1.08
Studies of the mechanism of action of the Shope rabbit papilloma virus. I. Concerning the nature of the induction of arginase in the infected cells. J Exp Med (1963) 1.02
Human cord blood cells as targets for gene transfer: potential use in genetic therapies of severe combined immunodeficiency disease. J Exp Med (1993) 0.99
Molecular biology, nucleic acids, and the future of medicine. Perspect Biol Med (1966) 0.99
Debunking the slippery slope argument against human germ-line gene therapy. J Med Philos (1994) 0.97
International perceptions and approval of gene therapy. Hum Gene Ther (1995) 0.96
Bioethics in medically assisted conception in the Muslim world. J Assist Reprod Genet (1995) 0.95
Lymphocyte gene therapy. Hum Gene Ther (1991) 0.93
Recent advances in the application of gene therapy to human disease. Am J Med (1995) 0.88
Can human genetic enhancement be prohibited? J Med Philos (1995) 0.87
Germ-line gene therapy: back to basics. J Med Philos (1991) 0.87
Human gene therapy: scientific and ethical considerations. J Med Philos (1985) 0.87
Use of the HPRT gene and the HAT selection technique in DNA-mediated transformation of mammalian cells: first steps toward developing hybridoma techniques and gene therapy. Bioessays (1992) 0.86
Altering human genes: social, ethical, and legal implications. Perspect Biol Med (1994) 0.86
Unsuccessful trial of gene replacement in arginase deficiency. Z Kinderheilkd (1975) 0.85
Ethical issues in manipulating the human germ line. J Med Philos (1991) 0.85
Treatment of patients with severe combined immunodeficiency due to adenosine deaminase (ADA) deficiency by autologous transplantation of genetically modified bone marrow cells. Hum Gene Ther (1992) 0.85
Hemophilia in the Talmud and rabbinic writings. Ann Intern Med (1969) 0.84
What the public thinks about biotechnology. Biotechnology (N Y) (1994) 0.83
Sounding boards. Gene therapy in human beings: when is it ethical to begin? N Engl J Med (1980) 0.83
Retrovirus-mediated gene transfer as an approach to analyze neuroblastoma relapse after autologous bone marrow transplantation. Hum Gene Ther (1992) 0.80
An early history of gene transfer and therapy. Hum Gene Ther (1994) 0.80
Transduction of mobilized peripheral blood CD34+ cells with the glucocerebrosidase cDNA. Gene Ther (1994) 0.79
Prospects for genetic intervention in man. Science (1970) 0.79
Cloning. Baillieres Clin Obstet Gynaecol (1991) 0.78
Regulation of somatic-cell therapy and gene therapy by the food and drug administration. N Engl J Med (1993) 0.77
National and international approaches to human germ-line gene therapy. Politics Life Sci (1994) 0.76
Germ-line gene therapy: a new stage of debate. Law Med Health Care (1992) 0.76
A Christian perspective on genetic engineering. Hum Gene Ther (1994) 0.76
Genetic engineering and our humanness. Hum Gene Ther (1994) 0.76
Clerics urge ban on altering germline cells. Science (1983) 0.76
The human genome project. Clin Obstet Gynecol (1993) 0.76
Commentary: how do we think about the ethics of human germ-line genetic therapy? J Med Philos (1991) 0.76
After gene therapy: issues in long-term clinical follow-up and care. Adv Genet (1995) 0.76
NIH censure for Dr Martin Cline: tighter rules for future research plans. Nature (1981) 0.76
Department of Health and Human Services, Public Health Service, National Institutes of Health. Recombinant DNA Advisory Committee. Human Gene Therapy Subcommittee. Minutes of Meeting, August 8, 1986. Recomb DNA Tech Bull (1986) 0.76
Recombinant DNA, cloning, genetic engineering, and Judaism. N Y State J Med (1979) 0.76
Germ-line engineering: a few European voices. J Med Philos (1991) 0.76
Gene therapy in Europe. Hum Gene Ther (1995) 0.76
Overview of regulation of gene therapy in Europe: a current statement including reference to US regulation. Hum Gene Ther (1995) 0.76
Germ-line gene therapy: no place in treatment of genetic disease. Hum Gene Ther (1994) 0.76
Ethics treaty to target genome implications. Nature (1994) 0.75
Obstetric outcome of in vitro fertilized pregnancies complicated by severe ovarian hyperstimulation syndrome: a multicenter study. Fertil Steril (1998) 2.73
Severe OHSS: An 'epidemic' of severe OHSS: a price we have to pay? Hum Reprod (1999) 2.39
The pathophysiology of ovarian hyperstimulation syndrome--views and ideas. Hum Reprod (1997) 2.05
Ovarian hyperstimulation syndrome: a current survey. Fertil Steril (1978) 1.78
The role of ultrasonography in the evaluation of endometrial receptivity following assisted reproductive treatments: a critical review. Hum Reprod Update (1997) 1.66
Cervical pregnancy: past and future. Obstet Gynecol Surv (1997) 1.66
New advances in sex preselection. Fertil Steril (1996) 1.57
The effect of estradiol depletion during the luteal phase on endometrial development. Fertil Steril (1994) 1.51
Copper and zinc levels in normal and malignant tissues. Cancer (1983) 1.48
Pheochromocytoma and pregnancy. Review of 89 cases. Obstet Gynecol Surv (1971) 1.46
Ovarian tissue banking in patients with Hodgkin's disease: is it safe? Fertil Steril (1998) 1.46
Postpartum umbilical cord blood collection for transplantation: a comparison of three methods. Am J Obstet Gynecol (2000) 1.45
Seasonality in human reproduction: an update. Hum Reprod (1992) 1.37
Cancer and male infertility. Hum Reprod (1995) 1.34
Intrauterine adhesions: an updated appraisal. Fertil Steril (1982) 1.19
Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril (1996) 1.16
Is the obstetric outcome of in vitro fertilized singleton gestations different from natural ones? A controlled study. Fertil Steril (1997) 1.15
Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. Fertil Steril (1987) 1.09
The value of laparoscopy in acute pelvic pain. Ann Surg (1975) 1.05
Reduced penetration of zona-free hamster ova by cryopreserved human spermatozoa. Arch Androl (1985) 1.03
Artificially induced endometrial cycles and establishment of pregnancies in the absence of ovaries. N Engl J Med (1986) 1.02
Pre-embryo donation: ethical and legal aspects. Int J Gynaecol Obstet (1998) 1.02
Familial occurrence of mature ovarian teratomas. Obstet Gynecol (1985) 1.02
Is laparoscopic appendectomy safe in pregnant women? Surg Endosc (2001) 1.01
Retinal hemorrhage in the newborn. Obstet Gynecol (1966) 1.00
Multiple primary malignant neoplasms in breast cancer patients in Israel. Cancer (1984) 0.99
A laparoscopic technique for obtaining ovarian cortical biopsy specimens for fertility conservation in patients with cancer. Fertil Steril (1999) 0.99
Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome. Hum Reprod (1996) 0.98
Collagen diseases in pregnancy. Obstet Gynecol Surv (1984) 0.97
The duties of ethical committees applied to human reproduction. J Assist Reprod Genet (1996) 0.97
Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil Steril (1997) 0.97
Multiple pregnancies following induction of ovulation. Fertil Steril (1981) 0.97
The right to an heir in the era of assisted reproduction. Hum Reprod (1998) 0.96
Social aspects in assisted reproduction. Hum Reprod Update (1999) 0.96
Granulosa cell tumors in Israel: a study of 172 cases. Gynecol Oncol (1983) 0.95
Ultrasonically guided oocyte recovery for in vitro fertilization: an improved method. J In Vitro Fert Embryo Transf (1986) 0.94
The effect of maternal age and socioeconomical background on neonatal outcome. Int J Gynaecol Obstet (1990) 0.94
The current status of sperm donation in assisted reproduction technology: ethical and legal considerations. J Assist Reprod Genet (1997) 0.94
Serum copper and zinc levels in patients taking oral contraceptives. Fertil Steril (1971) 0.94
Ovarian overstimulation syndrome. Fertil Steril (1969) 0.94
Pulmonary manifestations of severe ovarian hyperstimulation syndrome: a multicenter study. Fertil Steril (1999) 0.93
Is there really a decrease in sperm parameters among healthy young men? A survey of sperm donations during 15 years. J Assist Reprod Genet (1997) 0.93
Phaeochromocytoma and pregnancy--an updated appraisal. Aust N Z J Obstet Gynaecol (1982) 0.93
Legitimizing surrogacy in Israel. Hum Reprod (1997) 0.93
Jewish and Moslem aspects of in vitro fertilization and embryo transfer. Ann N Y Acad Sci (1985) 0.92
Regeneration of rabbit endometrium following intrauterine instillation of chemical agents. Gynecol Invest (1973) 0.92
Violence against women: the physician's role. Eur J Obstet Gynecol Reprod Biol (1998) 0.91
Accidental injury during pregnancy. Obstet Gynecol Surv (1989) 0.90
Human umbilical cord blood banking and transplantation: a state of the art. Eur J Obstet Gynecol Reprod Biol (2000) 0.89
Multifetal pregnancy reduction: a review of the world results for the period 1993-1996. Eur J Obstet Gynecol Reprod Biol (1997) 0.89
Infertility, ovulation induction treatments and the incidence of breast cancer--a historical prospective cohort of Israeli women. Breast Cancer Res Treat (2006) 0.89
The impact of endometrial preparation on implantation following cryopreserved-thawed-embryo transfer. Gynecol Obstet Invest (1996) 0.89
Intracytoplasmic sperm injection combined with preimplantation genetic diagnosis for the prevention of recurrent gestational trophoblastic disease. Hum Reprod (1997) 0.88
Prenatal sex determination and selection. Hum Reprod (1993) 0.88
Effect of bromocriptine treatment on male infertility associated with hyperprolactinemia. Arch Androl (1981) 0.87
Surgical treatment of vulvar lichen sclerosus: a review. Obstet Gynecol Surv (1996) 0.86
Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: a prospective study. Fertil Steril (1995) 0.86
Effect of oral contraceptives on blood viscosity. Am J Obstet Gynecol (1971) 0.86
The link between female infertility and cancer: epidemiology and possible aetiologies. Hum Reprod Update (1997) 0.86
Ovulation induction and risk of endometrial cancer: a pilot study. Eur J Obstet Gynecol Reprod Biol (2001) 0.85
The role of prostaglandins in ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol (1976) 0.85
In vitro fertilization and embryo transfer--legal and religious aspects in Israel, patient selection, and a modified technique for oocyte collection. Isr J Med Sci (1983) 0.85
Ovarian hyperstimulation syndrome with low oestradiol in non-classical 17 alpha-hydroxylase, 17,20-lyase deficiency: what is the role of oestrogens? Hum Reprod (1996) 0.85
Oral contraceptives and correlation between serum copper and ceruloplasmin levels. Int J Fertil (1972) 0.85
Effect of smoking on concentration, motility and zona-free hamster test on human sperm. Arch Androl (1992) 0.85
Monoamniotic twins: an update on antenatal diagnosis and treatment. J Matern Fetal Neonatal Med (2004) 0.84
Serum copper levels in normal and pathologic pregnancies. Am J Obstet Gynecol (1969) 0.84
Febrile morbidity in severe and critical ovarian hyperstimulation syndrome: a multicentre study. Hum Reprod (1998) 0.84
An epidemiologic study of carcinoma of the ovary in Israel. Isr J Med Sci (1969) 0.84
Medico-legal aspects of in vitro fertilization and embryo transfer practice. Obstet Gynecol Surv (1987) 0.84
Heterotopic pregnancy and assisted reproduction--an update. J Assist Reprod Genet (1996) 0.84
Successful pregnancies of two patients with relapsing thrombotic thrombocytopenic purpura. Int J Gynaecol Obstet (1989) 0.84
Serum copper level in gynecologic malignancies. Am J Obstet Gynecol (1987) 0.84
Plasma immunoglobulins in patients with severe ovarian hyperstimulation syndrome. Fertil Steril (1999) 0.83
Zona-free hamster ovum penetration assay as a screening procedure for in vitro fertilization. Fertil Steril (1983) 0.83
The effect of clomiphene citrate on early embryonic development, endometrium and implantation. Hum Reprod (1986) 0.83
Pulmonary complications following endotracheal intubation for anesthesia in breech extraction. Intensive Care Med (1985) 0.83
BRCA1 and BRCA2 gene mutations: decision-making dilemmas concerning testing and management. Obstet Gynecol Surv (2000) 0.83
Sperm donation in Israel. Hum Reprod (1995) 0.83
Delivery following intracytoplasmic injection of mature sperm cells recovered by testicular fine needle aspiration in a case of hypergonadotropic azoospermia due to maturation arrest. Hum Reprod (1996) 0.83
The effects of the socioeconomic status on the perinatal outcome of grand multipara. Eur J Obstet Gynecol Reprod Biol (1990) 0.83
Ruptured tubo-ovarian abscess complicating transcervical cryopreserved embryo transfer. Fertil Steril (1996) 0.83
Reduction of peritoneal adhesion formation by colchicine: a comparative study in the rat. Fertil Steril (1983) 0.83
The mode of action of bromocriptine. FEBS Lett (1981) 0.82
A birth in non-mosaic Klinefelter's syndrome after testicular fine needle aspiration, intracytoplasmic sperm injection and preimplantation genetic diagnosis. Hum Reprod (1998) 0.82
Cancer of ovary in Israel (1966-1971). Gynecol Oncol (1978) 0.82
Ovarian cancer. Geographical, host and environmental factors. An overview. Arch Gynecol (1983) 0.82
Quintuplet pregnancy. Obstet Gynecol (1975) 0.82
Pregnancy in the older woman: scientific and ethical aspects. Int J Gynaecol Obstet (1997) 0.82
Maternal-fetal conflict. Eur J Obstet Gynecol Reprod Biol (2000) 0.82
Mitral valvotomy during pregnancy. Surg Gynecol Obstet (1968) 0.82
Familial gonadal germinative failure: endocrine and human leukocyte antigen studies. Fertil Steril (1983) 0.82
I. Regeneration of rabbit endometrium following curettage. Am J Obstet Gynecol (1971) 0.81
The incidence of borderline ovarian tumors in Israel: a population-based study. Cancer (1998) 0.81
The ethical, legal and religious aspects of preembryo research. Eur J Obstet Gynecol Reprod Biol (1997) 0.81
Ranking the risk factors for cesarean: logistic regression analysis of a nationwide study. Obstet Gynecol (1990) 0.81
Estradiol and testosterone levels in the peripheral and ovarian circulations in patients with endometrial cancer. Cancer (1979) 0.81
Maternal and fetal serum copper levels at delivery. Biol Neonate (1972) 0.81
Insulin resistant and non-resistant polycystic ovary syndrome represent two clinical and endocrinological subgroups. Hum Reprod (1995) 0.81
Regeneration of rabbit endometrium after cryosurgery. Obstet Gynecol (1972) 0.81